Similar to EFV treatment, CYP46A1 overexpression in mouse-adapted scrapie prion–infected mouse neuroblastoma N2a cells reduced PrPSc, demonstrating a causal correlation between enhanced CYP46A1 activity and reduced PrPSc levels. The gene discussed is CYP46A1; the disease is neuroblastoma.